98%
921
2 minutes
20
Background & Aims: Crohn's disease (CD) strictures exhibit varying levels of inflammation and chronicity. We evaluate whether intestinal ultrasound (IUS) is accurate in characterizing stricture composition.
Methods: This prospective, cross-sectional study included patients with CD who underwent IUS prior to a small bowel segment resection. Histology in the resection specimen was assessed in location-matched tissue sections. Following a consensus session, 2 pathologists blindly assessed the predominant phenotype (inflammatory [IP], chronic [CP], or mixed [MP]) in the strictures. The primary objective of the study was to find a parameter to identify strictures with IP.
Results: A total of 36 patients were included (IP, 7 [20%]; CP, 16 [44%]; MP, 13 [36%]). Univariate analysis showed a positive association with an IP for loss of wall layer stratification (WLS) (odds ratio [OR], 7.86; P = .029) and higher contrast-enhanced ultrasound (CEUS) parameters. Bowel wall thickness (5.74 vs 7.46 mm; P = .002) was lower and color Doppler signal (OR, 0.14; P = .03) and loss of WLS (OR, 0.14; P = .027) were less present in CP. In multivariate analysis, loss of WLS and wash-in area under the curve at CEUS indicated an IP, whereas lower bowel wall thickness and color Doppler signal ≤2 indicated a CP. With these parameters, the Stricture Score Amsterdam was constructed and demonstrated accuracy for IP (area under the receiver operating curve, 0.88; P = .002) and CP (area under the receiver operating curve, 0.90; P < .0001), respectively. Inter-observer agreement for the score was good (intraclass correlation coefficient, 0.73; P < .0001).
Conclusion: A combination of IUS and CEUS is accurate to differentiate between inflammatory and chronic strictures in CD. The Stricture Score Amsterdam needs external validation and confirmation in its potential as a diagnostic decision aid when choosing between surgical and available medical treatments.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.cgh.2025.05.013 | DOI Listing |
Curr Opin Gastroenterol
August 2025
Yale University, Section of Digestive Diseases, New Haven, Connecticut, USA.
Purpose Of Review: Crohn's disease is a chronic, relapsing and remitting inflammatory process that can involve the entire length of the gastrointestinal tract. Upper gastrointestinal involvement (UGI) in Crohn's disease is present in up to 15% of patients and can present as a diagnostic challenge given nonspecific symptoms and overlapping disease entities. This review provides an update on diagnosing and risk stratifying UGI-CD.
View Article and Find Full Text PDFMedicine (Baltimore)
September 2025
Department of General Surgery, ZiGong First People's Hospital, Zigong, Sichuan Province, China.
Rationale: Gastric bezoar-induced duodenal obstruction represents a rare clinical entity with <0.5% incidence among mechanical bowel obstructions.
Patient Concerns: A 73-year-old female patient presented to our institution, manifesting acute abdominal syndrome characterized by progressive pain and distension.
Food Res Int
November 2025
College of Food Science and Technology, Nanjing Agricultural University, Nanjing 210095, PR China. Electronic address:
Flammulina velutipes is a major edible fungus with abundant yield and mature industrial production technology. Its main functional component, Flammulina velutipes polysaccharide, has huge development and utilization value. In light of the current uncertainty regarding the mechanisms by which Flammulina velutipes polysaccharides prevent colonic cell pyroptosis, the mechanisms of ultrasound-extracted Flammulina velutipes polysaccharide (FVPU2) in inhibiting colonic cell pyroptosis in mice were investigated, and compared with Flammulina velutipes polysaccharide extracted via hot water extraction (FVPH2).
View Article and Find Full Text PDFOpen Access Rheumatol
August 2025
Department of Rheumatology and Immunology, the First Affiliated Hospital, Jinan University, Guangzhou, 510632, People's Republic of China.
Objective: To evaluate the efficacy of baricitinib in combination therapy for managing refractory, rapidly progressive systemic sclerosis (SSc) with severe cardiac conduction defects and interstitial lung disease (ILD).
Methods: A 48-year-old male patient with SSc complicated by significant cardiac enlargement, third-degree atrioventricular block, heart failure, progressive ILD, and partial intestinal obstruction was included in the study. Prior treatments with mycophenolate mofetil (MMF), tacrolimus, and cyclophosphamide (CTX) had shown limited efficacy.
Front Microbiol
August 2025
Department of Allergy, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.
Introduction: Hepatic sinusoidal obstruction syndrome (HSOS) is a vascular liver disease with a high mortality rate, and treatment methods are limited. Rivaroxaban is an oral anticoagulant. This study aimed to investigate the pharmacological effect and potential mechanism of rivaroxaban on HSOS.
View Article and Find Full Text PDF